{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:37:57Z","timestamp":1767382677986,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1124\/dmd.117.077396","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:20:15Z","timestamp":1502151615000},"page":"1060-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["An Investigation into the Prediction of In Vivo Clearance for a Range of Flavin-containing Monooxygenase Substrates"],"prefix":"10.1016","volume":"45","author":[{"given":"Barry C.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Colclough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh Pilla","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Amberntsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.077396_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF00427432","article-title":"Absolute bioavailability of imipramine: influence of food","volume":"83","author":"Abernethyl","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/dmd.117.077396_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0940-2993(99)80004-9","article-title":"The effect of arginine-428 mutation on modulation of activity of human liver flavin monooxygenase 3 (FMO3) by imipramine and chlorpromazine.","volume":"51","author":"Adali","year":"1999","journal-title":"Exp Toxicol Pathol"},{"key":"10.1124\/dmd.117.077396_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/bdd.2510120702","article-title":"Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects","volume":"12","author":"Baldock","year":"1991","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.117.077396_bib4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1124\/dmd.107.015438","article-title":"Hepatic metabolism of MK-0457, a potent aurora kinase inhibitor: interspecies comparison and role of human cytochrome P450 and flavin-containing monooxygenase","volume":"35","author":"Ballard","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1124\/dmd.115.067769","article-title":"Determination of human hepatocyte intrinsic clearance for slowly metabolized compounds: comparison of a primary hepatocyte\/stromal cell co-culture with plated primary hepatocytes and HepaRG","volume":"44","author":"Bonn","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine. Pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.117.077396_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.pharmtox.46.120604.141043","article-title":"Human flavin-containing monooxygenases","volume":"46","author":"Cashman","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.117.077396_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0090-9556(25)07460-4","article-title":"Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine","volume":"21","author":"Cashman","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib9","first-page":"137","article-title":"Pharmacokinetic and bioequivalence study of itopride HCl in healthy volunteers","volume":"60","author":"Cho","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/dmd.117.077396_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1254\/jjp.84.213","article-title":"Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450","volume":"84","author":"Chung","year":"2000","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/dmd.117.077396_bib11","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1124\/dmd.113.054031","article-title":"A perspective on the prediction of drug pharmacokinetics and disposition in drug research and development","volume":"41","author":"Di","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1021\/acschembio.5b01016","article-title":"Biocatalytic characterization of human FMO5: unearthing Baeyer-Villiger reactions in humans","volume":"11","author":"Fiorentini","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1124\/dmd.117.077396_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/dmd.30.10.1087","article-title":"Flavin-containing monooxygenase activity in hepatocytes and microsomes: in vitro characterization and in vivo scaling of benzydamine clearance","volume":"30","author":"Fisher","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib14","first-page":"418","article-title":"Pharmacokinetics and bioavailability of tamoxifen in postmenopausal healthy women","volume":"46","author":"Fuchs","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/dmd.117.077396_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12934-015-0262-0","article-title":"Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesis","volume":"14","author":"Geier","year":"2015","journal-title":"Microb Cell Fact"},{"key":"10.1124\/dmd.117.077396_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/138920006776359266","article-title":"The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions","volume":"7","author":"Grime","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.117.077396_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/mp300476z","article-title":"Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics","volume":"10","author":"Grime","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.117.077396_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1124\/jpet.300.2.355","article-title":"The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes","volume":"300","author":"Hines","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.077396_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/00498250110055488","article-title":"Characterization of moclobemide N-oxidation in human liver microsomes.","volume":"31","author":"Hoskins","year":"2001","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.117.077396_bib20","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1124\/dmd.114.057984","article-title":"Aldehyde oxidase activity in donor-matched fresh and cryopreserved human hepatocytes and assessment of variability in 75 donors","volume":"42","author":"Hutzler","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/15376516.2016.1225141","article-title":"The impact of variation in scaling factors on the estimation of internal dose metrics: a case study using bromodichloromethane (BDCM)","volume":"26","author":"Kenyon","year":"2016","journal-title":"Toxicol Mech Methods"},{"key":"10.1124\/dmd.117.077396_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0090-9556(24)15176-8","article-title":"Size limits of thiocarbamides accepted as substrates by human flavin-containing monooxygenase 1","volume":"28","author":"Kim","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib23","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1124\/dmd.115.064790","article-title":"In vitro characterization of the human liver microsomal kinetics and reaction phenotyping of olanzapine metabolism","volume":"43","author":"Korprasertthaworn","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602530600569919","article-title":"The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines","volume":"38","author":"Krueger","year":"2006","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.117.077396_bib25","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0026-895X(24)12055-X","article-title":"The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate","volume":"28","author":"Mushiroda","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0773.1978.tb02169.x","article-title":"The kinetics of imipramine-N-oxide in man","volume":"42","author":"Nagy","year":"1978","journal-title":"Acta pharmacologica et toxicologica"},{"key":"10.1124\/dmd.117.077396_bib26","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1124\/dmd.104.000802","article-title":"Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin","volume":"33","author":"Parte","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tips.2008.03.004","article-title":"Flavin-containing monooxygenases: mutations, disease and drug response","volume":"29","author":"Phillips","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/dmd.117.077396_bib28","first-page":"80","article-title":"Single-dose pharmacokinetics of the MAO-inhibitor moclobemide in man","volume":"34","author":"Raaflaub","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/dmd.117.077396_bib29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/dmd.105.004259","article-title":"A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes","volume":"33","author":"Riley","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.dmpk.2014.09.006","article-title":"Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans","volume":"30","author":"Taniguchi-Takizawa","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.117.077396_bib31","first-page":"47","article-title":"Steady-state bioequivalence study of clozapine tablet in schizophrenic patients.","volume":"8","author":"Tassaneeyakul","year":"2005","journal-title":"J Pharm Pharm Sci"},{"key":"10.1124\/dmd.117.077396_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00280-010-1318-9","article-title":"Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors","volume":"67","author":"Traynor","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.117.077396_bib33","first-page":"524","article-title":"N-oxygenation of clozapine by flavin-containing monooxygenase","volume":"25","author":"Tugnait","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077396_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2125.1982.tb01961.x","article-title":"Ranitidine: single dose pharmacokinetics and absolute bioavailability in man","volume":"14","author":"van Hecken","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.117.077396_bib35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0016-5085(78)90762-X","article-title":"Bioavailability of cimetidine in man","volume":"74","author":"Walkenstein","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.117.077396_bib36","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1124\/dmd.110.033555","article-title":"In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase","volume":"38","author":"Zientek","year":"2010","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.077396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:32:48Z","timestamp":1739903568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624054357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0090955624054357"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.077396","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Investigation into the Prediction of In Vivo Clearance for a Range of Flavin-containing Monooxygenase Substrates","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.077396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}